Acknowledgements
We wish to thank Dr. Emilia Niemiec, Dr. Andelka Phillips, and Professor Jessica Almqvist for discussions on earlier drafts of the chapters at the Nordic Permed Law Symposium Genome Editing, Health innovation, and Responsible Regulation on November 3–4, 2021. Moreover, we are grateful to Dr. Emilia Niemiec for her insightful comments on the scientific aspects of genome editing.
Timo Minssen’s research for this contribution was supported by a Novo Nordisk Foundation for a scientifically independent Collaborative Research Programme in Biomedical Innovation Law (Grant agreement number NNF17SA0027784).